Literature DB >> 24525587

Prognostic value of semiquantification NP-59 SPECT/CT in primary aldosteronism patients after adrenalectomy.

Ching-Chu Lu1, Vin-Cent Wu, Kwan-Dun Wu, Kao-Lang Liu, Wei-Chou Lin, Mei-Fang Cheng, Kai-Yuan Tzen, Ruoh-Fang Yen.   

Abstract

PURPOSE: Primary aldosteronism (PA), characterized by an excessive production of aldosterone, affects 5-13 % of patients with hypertension. Accurate strategies are needed for the timely diagnosis of PA to allow curability and prevention of excessive cardiovascular events and related damage. This study aimed to evaluate the usefulness of semiquantification of (131)I-6β-iodomethyl-norcholesterol (NP-59) single photon emission computed tomography (SPECT)/CT in differentiating aldosterone-producing adenoma (APA) from idiopathic adrenal hyperplasia (IAH) and in predicting clinical outcomes after adrenalectomy.
METHODS: We retrospectively reviewed 49 PA patients who had undergone adrenalectomy after NP-59 SPECT/CT within 1 year. A conventional visual scale (VS) and two semiquantitative parameters generated from SPECT/CT, adrenal to liver ratio (ALR) and lesion to contralateral ratio of bilateral adrenal glands (CON), with cutoff values calculated by receiver-operating characteristic (ROC) analysis, were compared with pathology results and postsurgical outcomes to determine the accuracy.
RESULTS: An ALR cutoff of 1.84 and a CON cutoff of 1.15 showed an ability to distinguish adenoma from hyperplasia similar to VS (p = 0.2592 and 0.1908, respectively). An ALR cutoff of 2.28 and a CON cutoff of 1.11 yielded the highest sensitivity and specificity to predict postsurgical outcomes, and an ALR of 2.28 had an ability superior to VS (p = 0.0215), while a CON of 1.11 did not (p = 0.1015). Patients with either ALR or CON greater than the cutoff had a high probability of positive postsurgical outcomes (n = 36/38), while patients with both ALR and CON less than the cutoff had a low probability of positive postsurgical outcomes (n = 2/11).
CONCLUSION: Semiquantification of NP-59 scintigraphy has an ability similar to VS in differentiating APA from IAH, but an excellent ability to predict postsurgical outcomes of adrenalectomy. An ALR or CON greater than the cutoff strongly suggests benefits from adrenalectomy, and both ALR and CON less than the cutoff implies a reduced chance of improvement in postsurgical outcome.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24525587     DOI: 10.1007/s00259-014-2692-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  39 in total

1.  Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group).

Authors:  Chin-Chi Kuo; Vin-Cent Wu; Kuo-How Huang; So-Mong Wang; Chin-Chen Chang; Ching-Chu Lu; Wei-Shun Yang; Ching-Wei Tsai; Chun-Fu Lai; Tzong-Yann Lee; Wei-Chou Lin; Ming-Shou Wu; Yen-Hung Lin; Tzong-Shinn Chu; Chien-Yu Lin; Hung-Wei Chang; Wei-Jei Wang; Tze-Wah Kao; Shih-Chieh Chueh; Kwan-Dun Wu
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2011-03-10       Impact factor: 1.636

2.  Visualization of human adrenal glands in vivo by scintillation scanning.

Authors:  W H Beierwaltes; L M Lieberman; A N Ansari; H Nishiyama
Journal:  JAMA       Date:  1971-04-12       Impact factor: 56.272

3.  The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism.

Authors:  Gian Paolo Rossi; Marlena Barisa; Bruno Allolio; Richard J Auchus; Laurence Amar; Debbie Cohen; Christoph Degenhart; Jaap Deinum; Evelyn Fischer; Richard Gordon; Ralph Kickuth; Gregory Kline; Andre Lacroix; Steven Magill; Diego Miotto; Mitsuhide Naruse; Tetsuo Nishikawa; Masao Omura; Eduardo Pimenta; Pierre-François Plouin; Marcus Quinkler; Martin Reincke; Ermanno Rossi; Lars Christian Rump; Fumitoshi Satoh; Leo Schultze Kool; Teresa Maria Seccia; Michael Stowasser; Akiyo Tanabe; Scott Trerotola; Oliver Vonend; Jiri Widimsky; Kwan-Dun Wu; Vin-Cent Wu; Achille Cesare Pessina
Journal:  J Clin Endocrinol Metab       Date:  2012-03-07       Impact factor: 5.958

4.  Adrenal venous sampling: evaluation of the German Conn's registry.

Authors:  Oliver Vonend; Nora Ockenfels; Xing Gao; Bruno Allolio; Katharina Lang; Knut Mai; Ivo Quack; Andreas Saleh; Christoph Degenhart; Jochen Seufert; Lysann Seiler; Felix Beuschlein; Marcus Quinkler; Petr Podrabsky; Martin Bidlingmaier; Reinhard Lorenz; Martin Reincke; Lars Christian Rump
Journal:  Hypertension       Date:  2011-03-07       Impact factor: 10.190

Review 5.  A review of the medical treatment of primary aldosteronism.

Authors:  P O Lim; W F Young; T M MacDonald
Journal:  J Hypertens       Date:  2001-03       Impact factor: 4.844

6.  SPECT semiquantitative analysis of adrenocortical (131)I-6 beta iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma.

Authors:  Giuseppe La Cava; Alessio Imperiale; Catia Olianti; G Riccardo Gheri; Cristina Ladu; Massimo Mannelli; Alberto Pupi
Journal:  J Nucl Med       Date:  2003-07       Impact factor: 10.057

7.  Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia.

Authors:  V C Wu; S C Chueh; H W Chang; W C Lin; K L Liu; H Y Li; Y H Lin; K D Wu; B S Hsieh
Journal:  QJM       Date:  2008-01

8.  Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?

Authors:  C A Proye; E A Mulliez; B M Carnaille; M Lecomte-Houcke; M Decoulx; J L Wémeau; J Lefebvre; A Racadot; O Ernst; D Huglo; A Carré
Journal:  Surgery       Date:  1998-12       Impact factor: 3.982

9.  131I-6beta-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results.

Authors:  Ruoh-Fang Yen; Vin-Cent Wu; Kao-Lang Liu; Mei-Fang Cheng; Yen-Wen Wu; Shih-Chieh Chueh; Wei-Chou Lin; Kwan-Dun Wu; Kai-Yuan Tzen; Ching-Chu Lu
Journal:  J Nucl Med       Date:  2009-09-16       Impact factor: 10.057

10.  Outcomes of laparoscopic adrenalectomy for hyperaldosteronism.

Authors:  Tony C Pang; Chris Bambach; Judith C Monaghan; Stan B Sidhu; Alex Bune; Leigh W Delbridge; Mark S Sywak
Journal:  ANZ J Surg       Date:  2007-09       Impact factor: 1.872

View more
  7 in total

1.  Endocrine radionuclide scintigraphy with fusion single photon emission computed tomography/computed tomography.

Authors:  Ka-Kit Wong; Arpit Gandhi; Benjamin L Viglianti; Lorraine M Fig; Domenico Rubello; Milton D Gross
Journal:  World J Radiol       Date:  2016-06-28

Review 2.  Aldosterone excess and resistant hypertension: investigation and treatment.

Authors:  Michael Stowasser
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

Review 3.  Approach to the surgical management of primary aldosteronism.

Authors:  Maurizio Iacobone; Marilisa Citton; Giovanni Viel; Gian Paolo Rossi; Donato Nitti
Journal:  Gland Surg       Date:  2015-02

4.  NP-59 Adrenal Scintigraphy as an Imaging Biomarker to Predict KCNJ5 Mutation in Primary Aldosteronism Patients.

Authors:  Ching-Chu Lu; Ruoh-Fang Yen; Kang-Yung Peng; Jei-Yie Huang; Kwan-Dun Wu; Jeff S Chueh; Wan-Yu Lin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-28       Impact factor: 5.555

Review 5.  Nuclear imaging in the diagnosis of primary aldosteronism.

Authors:  Andrew S Powlson; Mark Gurnell; Morris J Brown
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-06       Impact factor: 3.243

Review 6.  Targeted Molecular Imaging in Adrenal Disease-An Emerging Role for Metomidate PET-CT.

Authors:  Iosif A Mendichovszky; Andrew S Powlson; Roido Manavaki; Franklin I Aigbirhio; Heok Cheow; John R Buscombe; Mark Gurnell; Fiona J Gilbert
Journal:  Diagnostics (Basel)       Date:  2016-11-18

7.  Surgical outcomes of patients with primary aldosteronism lateralized with I-131-6 β-iodomethyl-norcholesterol single photon emission/computed tomography without discontinuation or modification of antihypertensive medications.

Authors:  Chia-Hui Chang; Stephen Shei-Dei Yang; Yao-Chou Tsai; Shi-Wen Kuo; Shiou-Chi Cherng; Ching-Chu Lu; Ruoh-Fang Yen; Vin-Cent Wu; Ya-Hui Hu
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2018 Jul-Sep
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.